•To describe data
resources available to ODS relevant to
the issue of suicidal behaviors with pediatric use of antidepressant drugs
–Databases
•FDA
postmarketing surveillance database
•Population-based
epidemiological databases
•To describe context of
spontaneous postmarketing reports
of pediatric suicidality with newer antidepressant
therapy